Items where authors include "Zetterberg, H."

Article

Taquet, M., Skorniewska, Z., Zetterberg, H. orcid.org/0000-0003-3930-4354 et al. (1262 more authors) (2023) Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury. Brain Communications, 6 (1). fcad357. ISSN 2632-1297

Taquet, M., Skorniewska, Z., Zetterberg, H. orcid.org/0000-0003-3930-4354 et al. (1262 more authors) (2023) Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury. Brain Communications, 6 (1). fcad357. ISSN 2632-1297

Blennow, K., Galasko, D., Perneczky, R. orcid.org/0000-0003-1981-7435 et al. (7 more authors) (2023) The potential clinical value of plasma biomarkers in Alzheimer's disease. Alzheimer's & Dementia. ISSN 1552-5260

Gonzalez-Robles, C., Weil, R.S., van Wamelen, D. et al. (20 more authors) (2023) Outcome measures for disease-modifying trials in Parkinson’s disease: consensus paper by the EJS ACT-PD multi-arm multi-stage trial initiative. Journal of Parkinson's Disease, 13 (6). pp. 1011-1033. ISSN 1877-7171

Foltynie, T. orcid.org/0000-0003-0752-1813, Gandhi, S., Gonzalez-Robles, C. et al. (85 more authors) (2023) Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson’s disease. Brain. awad063. ISSN 0006-8950

Michalowska, M.M., Herholz, K., Hinz, R. et al. (9 more authors) (2022) Evaluation of in vivo staging of amyloid deposition in cognitively unimpaired elderly aged 78–94. Molecular Psychiatry, 27 (10). pp. 4335-4342. ISSN 1359-4184

Chouliaras, L., Thomas, A., Malpetti, M. et al. (10 more authors) (2022) Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy. Journal of Neurology, Neurosurgery & Psychiatry, 93 (6). pp. 651-658. ISSN 0022-3050

Giovannelli, I., Bayatti, N., Brown, A. et al. (23 more authors) (2021) Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2. Brain Communications, 3 (3). fcab141. ISSN 2632-1297

Shribman, S., Heller, C., Burrows, M. et al. (17 more authors) (2021) Plasma neurofilament light as a biomarker of neurological involvement in Wilson's disease. Movement Disorders, 36 (2). pp. 503-508. ISSN 0885-3185

Camu, W., Mickunas, M., Veyrune, J.-L. et al. (18 more authors) (2020) Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial. EBioMedicine, 59. 102844. ISSN 2352-3964

De, S. orcid.org/0000-0003-1675-0773, Whiten, D.R., Ruggeri, F.S. et al. (14 more authors) (2019) Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer’s disease progression. Acta Neuropathologica Communications, 7 (1). 120. ISSN 2051-5960

Drews, A., De, S. orcid.org/0000-0003-1675-0773, Flagmeier, P. et al. (14 more authors) (2017) Inhibiting the Ca 2+ influx induced by human CSF. Cell Reports, 21 (11). pp. 3310-3316. ISSN 2211-1247